Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 17 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Set to Capitalize on North American Push to Secure Rare Earth Supply Chains
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid…
-
SPARC AI Inc. (SPAIF) Is Developing a Target Acquisition and Navigation System That Doesn’t Rely on GPS
SPARC AI provides GPS-free autonomous navigation and target acquisition systems for drones and other edge…
-
A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Expands Leadership, Global Presence in Intelligent Retail Solutions
A2Z Cust2Mate Solutions announced key additions to its global sales leadership team to accelerate growth…